Stephen Divers's most recent trade in American Oncology Network Inc - Ordinary Shares - Class A was a trade of 5,000 Class A Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on May 24, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
American Oncology Network ... | Stephen Divers | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.15 per share. | 24 May 2024 | 5,000 | 62,470 | - | 2.2 | 10,750 | Class A Common Stock |
American Oncology Network ... | Stephen Divers | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. | 20 Mar 2024 | 8,554 | 57,470 | - | 5.7 | 48,758 | Class A Common Stock |
American Oncology Network ... | Stephen Divers | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 5.69 per share. | 19 Mar 2024 | 59,500 | 66,024 | - | 5.7 | 338,555 | Class A Common Stock |
American Oncology Network ... | Stephen Divers | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.10 per share. | 05 Jan 2024 | 3,369 | 6,524 | - | 6.1 | 20,551 | Class A Common Stock |
American Oncology Network ... | Stephen Divers | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 9,893 | 9,893 | - | 0 | Class A Common Stock |